莱茵生物停牌，筹划控制权变更！

Group 1 - The company Rhine Biotech (002166) announced a stock suspension starting December 10 due to plans for a change in control, issuance of shares, and cash payment for asset acquisition, with the suspension expected to last no more than 10 trading days [1][3] - The controlling shareholder Qin Benjun is planning to transfer part of his shares and relinquish voting rights, with the counterparty for the share transfer being Guangzhou Defu Nutrition Investment Partnership [1][3] - Rhine Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of share issuance and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1][3] Group 2 - Beijing Jinkangpu, established in 2004, specializes in the compounding, testing, sales, and technical development and services of food nutrition fortifiers [2][4] - Rhine Biotech's core product is natural sweeteners, indicating a potential synergy with Beijing Jinkangpu's offerings in the food technology sector [2][4]